Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Carlos E. Riaño-Medina
Soluble FMS-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia
Frontiers in Physiology
Physiology
Related publications
Placental Growth Factor, Soluble FMS-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
Mediators of Inflammation
Immunology
Cell Biology
Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble FMS-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia
Hypertension
Internal Medicine
Resveratrol Inhibits Release of Soluble FMS-Like Tyrosine Kinase (sFlt-1) and Soluble Endoglin and Improves Vascular Dysfunction – Implications as a Preeclampsia Treatment
Scientific Reports
Multidisciplinary
Soluble FMS-Like Tyrosine Kinase 1 Localization in Renal Biopsies of Chronic Kidney Disease
Kidney International Reports
Nephrology
Predictive Value of Soluble FMS-Like Tyrosine Kinase-1 Against Placental Growth Factor for Preeclampsia in a Chinese Pregnant Women Population
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
Soluble FMS-Like Tyrosine Kinase-1 Is a Marker of Endothelial Dysfunction During Sepsis
Journal of Clinical Medicine Research
Maternal Plasma Soluble FMS-Like Tyrosine Kinase-1 and Free Vascular Endothelial Growth Factor at 11 to 13 Weeks of Gestation in Preeclampsia
Prenatal Diagnosis
Gynecology
Genetics
Obstetrics
P103: Soluble FMS-like Tyrosine Kinase-1 (sFlt-1) Potential Biomarker for Early Pregnancy Loss Prevention
American Journal of Reproductive Immunology
Gynecology
Reproductive Medicine
Immunology
Obstetrics
Allergy
FLT3 (FMS-like Tyrosine Kinase 3)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
